» Articles » PMID: 2413938

The Positive Inotropic Action of the Nifedipine Analogue, Bay K 8644, in Guinea-pig and Rat Isolated Cardiac Preparations

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1985 Sep 1
PMID 2413938
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The inotropic effect of Bay K 8644 has been studied in rat and guinea-pig atria and ventricular strips stimulated at 1 Hz, in a medium containing CaCl2 1.8 mM. The positive inotropic effect at maximal effective concentrations of Bay K 8644 was in the following order: guinea-pig ventricle greater than rat ventricle greater than guinea-pig atria greater than greater than rat atria. In rat preparations, the tension recorded at maximum effective concentrations of Bay K 8644 was similar at three different calcium concentrations (0.7, 1.8, 3.0 mM). The amplitude of the positive inotropic effect evoked by Bay K 8644 increased when atrial and ventricular contractions were reduced by lowering the external calcium concentration. The contractile tension reached in the presence of maximum effective concentrations of Bay K 8644 (3 X 10(-7) -1 X 10(-6) M) was greater than that produced by the maximum effective concentration of external calcium (3 mM) in rat ventricles but not in rat atria. High doses of nifedipine (3 X 10(-7) -1 X 10(-6) M) depressed the contraction of rat atria more than the contraction of rat ventricles. In rat ventricles, nifedipine shifted to the right the inotropic dose-effect curve of Bay K 8644. It is concluded that the interaction between nifedipine and Bay K 8644 occurred at the same binding sites. These sites have some characteristics of the low affinity binding sites of nifedipine and other related dihydropyridines.

Citing Articles

Cardioselectivity of calcium antagonists.

GODFRAIND T Cardiovasc Drugs Ther. 1994; 8 Suppl 2:353-64.

PMID: 7947378 DOI: 10.1007/BF00877320.


Biphasic inotropic effects of a Ca2+ channel activator CGP28392 in rat myocardium: possible relation to intracellular Ca2+ release.

Kobrinsky E, Saxon M Br J Pharmacol. 1987; 92(3):499-504.

PMID: 3427265 PMC: 1853689. DOI: 10.1111/j.1476-5381.1987.tb11349.x.


Positive inotropic effects of calcium channel antagonists are not necessarily caused by partial calcium channel agonism.

Punt N, Van Amsterdam F, Goddijn M, Haas M, Zaagsma J Naunyn Schmiedebergs Arch Pharmacol. 1988; 338(2):211-4.

PMID: 3185748 DOI: 10.1007/BF00174873.


Stereoisomers of BAY K 8644 show opposite activities in the normal and ischaemic rat heart. A comparison with nifedipine.

Van Amsterdam F, Punt N, Haas M, Zaagsma J Naunyn Schmiedebergs Arch Pharmacol. 1989; 339(6):647-52.

PMID: 2475789 DOI: 10.1007/BF00168657.


Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activators related to Bay K 8644 in smooth muscle, cardiac muscle and neuronal preparations.

Kwon Y, Franckowiak G, Langs D, Hawthorn M, Joslyn A, Triggle D Naunyn Schmiedebergs Arch Pharmacol. 1989; 339(1-2):19-30.

PMID: 2471085 DOI: 10.1007/BF00165121.


References
1.
Bellemann P, Ferry D, Lubbecke F, Glossman H . [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. Arzneimittelforschung. 1981; 31(12):2064-7. View

2.
ARUNLAKSHANA O, SCHILD H . Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959; 14(1):48-58. PMC: 1481829. DOI: 10.1111/j.1476-5381.1959.tb00928.x. View

3.
Lee K, Tsien R . Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature. 1983; 302(5911):790-4. DOI: 10.1038/302790a0. View

4.
Schramm M, Thomas G, Towart R, Franckowiak G . Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature. 1983; 303(5917):535-7. DOI: 10.1038/303535a0. View

5.
Marsh J, Loh E, Lachance D, Barry W, Smith T . Relationship of binding of a calcium channel blocker to inhibition of contraction in intact cultured embryonic chick ventricular cells. Circ Res. 1983; 53(4):539-43. DOI: 10.1161/01.res.53.4.539. View